April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sà rl is recalling Cerenovus CEREBASE DA Guide Sheath due to a crack found in the far end of the catheter ...
Balloon Catheter
This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.
April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sà rl is recalling Cerenov ...
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...
March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...
March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led ...
March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration (FDA) ...
February 9, 2024 — BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily ...
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...
January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural ...
November 1, 2023 — The VIVA Foundation has announced the results for the first Late-Breaking Clinical Trial sessions at ...
October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT ...
October 16, 2023 — A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart ...
September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
September 14, 2023 — BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry ...
September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease t ...